Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Oral Dydrogesterone Versus Micronized Vaginal Progesterone for Luteal Phase Support in In Vitro Fertilisation (IVF)/ IntraCytoplasmic Sperm Injection (ICSI): Pharmacokinetics and the Impact on the Endometrium, the Microbiota of the Genital Tract and the Peripheral Immunology. Double Blind Crossover Study.

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT03677336
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:37:54.194375+00:00
Published At
2020-12-17T00:00:00+00:00
Record Updated At
2020-12-17
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Infertility, Female", "Infertility", "Genital Diseases, Male", "Genital Diseases, Female", "Progesterone", "Dydrogesterone", "Hormones", "Hormones, Hormone Substitutes, and Hormone Antagonists", "Physiological Effects of Drugs", "Progestins"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2020-12-17"
protocolSection.identificationModule.nctId
"NCT03677336"
protocolSection.identificationModule.officialTitle
"Oral Dydrogesterone Versus Micronized Vaginal Progesterone for Luteal Phase Support in In Vitro Fertilisation (IVF)/ IntraCytoplasmic Sperm Injection (ICSI): Pharmacokinetics and the Impact on the Endometrium, the Microbiota of the Genital Tract and the Peripheral Immunology. Double Blind Crossover Study."
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE4"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Infertility, Female (protocolSection.conditionsModule.conditions)
  • Infertility (protocolSection.conditionsModule.conditions)
  • Genital Diseases, Male (protocolSection.conditionsModule.conditions)
  • Genital Diseases, Female (protocolSection.conditionsModule.conditions)
  • Progesterone (protocolSection.conditionsModule.conditions)
  • Dydrogesterone (protocolSection.conditionsModule.conditions)
  • Hormones (protocolSection.conditionsModule.conditions)
  • Hormones, Hormone Substitutes, and Hormone Antagonists (protocolSection.conditionsModule.conditions)
  • Physiological Effects of Drugs (protocolSection.conditionsModule.conditions)
  • Progestins (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.